It has been a busy few weeks, with several department members attending and presenting their work at conferences around the globe.
Aniek Markus presented her work on the model stability of machine learning and why predicting risk cannot identify risk factors at the Machine Learning for Healthcare conference in Durham, USA.
Several members also attended IPCE in Copenhagen, Denmark.
Victor Pera presented his research on medication errors within the spontaneous reporting system FAERS and Alexandros Rekkas presented his work on his implementation of the assessment of heterogeneity of treatment effect using the OMOP-CDM. An update of the COVID-19 pharmacoepidemiological battlefield was also given by Daniel Prieto-Alhambra.
Alex further attended the International Society for Clinical Biostatistics (ISCB) conference in Newcastle, UK, where he presented his work on a simulation study comparing risk-based approaches for the estimation of individualized treatment effects from randomized controlled trials.
Looking back on an amazing 3 days! Last week, our HDS team hosted the third OHDSI Europe Symposium at the SS Rotterdam; the event was fully booked, with 350 participants, 24 plenary presentations, and 80 posters. Great to see many members of our team (more than 15) contributing to the collaborator showcase and several members (Alex, Aniek & Cynthia) presenting their work during the rapid fire session.
Thanks all participants for the inspiring talks, discussions and chats!
All information and content from the Symposium can be found on the OHDSI Europe Website.